BioSpace News Archive

Submitted proposal to BARDA for start-to-finish funding to develop an approved, commercial Ii-Key peptide vaccine against the SARS-CoV-2 coronavirus SARS-CoV-2 epitope identification and selection completed Initiated GLP manufacturing of synthetic Ii-Key-SARS-CoV-2 peptides for screening in “Ex-vivo” human trial in blood samples from COVID-19 convalescent (recovered) patients Obtained letters of support for BARDA Application from scientific partners, prestigious universities, major contract

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biology solutions provider, owner of Clean Beauty consumer brands and provider of proprietary functional ingredients, today announced that the company will host a conference call for investors and analysts on Friday, May 8, 2020 at 6:00 a.m. PT ( 9:00 a.m. ET ) to discuss its first

DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include behavioral health coaching for stress, anxiety and loneliness, conditions which have recently escalated due to COVID-19 social distancing restriction

Primary PartnerCare quickly modified its proprietary risk algorithm to efficiently deploy clinical resources to its over 20,000 Medicare patients during COVID-19 pandemic

Michael J. Fox Foundation Launches Limited Series Podcast to be Hosted by Award-winning Podcaster Larry Gifford

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, will report first quarter financial results following the close of U.S. financial markets on May 12 and host a conference call at 1:30 p.m. PT/4:30 p.m. ET to discuss the results and provide operational updates

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the first quarter ended March 31, 2020, after the market close on Monday, May 11, and will host a corporate update conference call at 4:30pm Eastern Time. Monday, May 11 th

EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Kelly Baker to Chief Financial Officer (CFO).

Aspargo Laboratories, Inc. (Aspargo), a privately held, clinical stage pharmaceutical company, today announced the results of its pre-Investigational New Drug (pre-IND) meeting with the United States Food & Drug Administration (FDA), where the FDA addressed Aspargo’s questions and provided guidance on the Company’s Sildenafil Oral Sp

Brand New US-based pharmaceutical manufacturer, Tailstorm Health, Inc., DBA Medivant Healthcare, will begin to roll out sterile single dose liquid injectable medications on the FDA’s Drug Shortage List.